Search hospitals > Georgia > Albany
Phoebe Putney Memorial Hospital
Claim this profileAlbany, Georgia 31701
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Colorectal Cancer
72 reported clinical trials
2 medical researchers
Summary
Phoebe Putney Memorial Hospital is a medical facility located in Albany, Georgia. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Colorectal Cancer and other specialties. Phoebe Putney Memorial Hospital is involved with conducting 72 clinical trials across 137 conditions. There are 2 research doctors associated with this hospital, such as Sharad Ghamande and Vamsi Kota, MD.Area of expertise
1Cancer
Global LeaderStage II
HER2 positive
Stage I
2Breast Cancer
Global LeaderHER2 negative
ER positive
PR positive
Top PIs
Sharad GhamandeAugusta University Medical Center1 year of reported clinical research
Expert in Cancer
Expert in Breast Cancer
69 reported clinical trials
146 drugs studied
Vamsi Kota, MDAugusta University Medical Center3 years of reported clinical research
Studies Leukemia
Studies Lymphoblastic Leukemia-Lymphoma
8 reported clinical trials
37 drugs studied
Clinical Trials running at Phoebe Putney Memorial Hospital
Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Colorectal Cancer
Cancer
Pancreatic Cancer
ALK Gene Rearrangement
Head and Neck Cancers
Adenosquamous Carcinoma
Pancreatic Carcinoma
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Phoebe Putney Memorial Hospital?
Phoebe Putney Memorial Hospital is a medical facility located in Albany, Georgia. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Colorectal Cancer and other specialties. Phoebe Putney Memorial Hospital is involved with conducting 72 clinical trials across 137 conditions. There are 2 research doctors associated with this hospital, such as Sharad Ghamande and Vamsi Kota, MD.